Journal article

Cohort Profile: The International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3) Study

Jason Grebely, Meghan D Morris, Thomas M Rice, Julie Bruneau, Andrea L Cox, Arthur Y Kim, Barbara H McGovern, Naglaa H Shoukry, Georg Lauer, Lisa Maher, Andrew R Lloyd, Margaret Hellard, Maria Prins, Gregory J Dore, Kimberly Page

International Journal of Epidemiology | OXFORD UNIV PRESS | Published : 2013

University of Melbourne Researchers

Grants

Awarded by National Institute on Drug Abuse


Awarded by NIH


Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES


Awarded by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES


Awarded by NATIONAL INSTITUTE ON DRUG ABUSE


Awarded by Alberta Innovates


Funding Acknowledgements

The InC<SUP>3</SUP> Study is supported by the National Institute on Drug Abuse (award number R01DA031056). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health. The Kirby Institute for Infection and Immunity in Society is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. J.G. is supported by a National Health and Medical Research Council Career Development Fellowship. J.B. and N.H.S. are supported by Fonds de la Recherche du Quebec-Sante Research Career Awards. G. D. and A. L. are supported by National Health and Medical Research Council Practitioner Research Fellowships. M. H. and L. M. were supported by National Health and Medical Research Council Senior Research Fellowships and M. H. additionally by a VicHealth Senior Research Fellowship. Other research support includes NIH U19 AI088791 (A. C.), NIH U19 AI066345 (A. K., G. L. and B. M.), U19 AI082630 (NIAID; A. K., G. L. and B. M.), R01 DA033541 (NIDA; A. K., G. L. and B. M.), and RO1 DA016017 (K. P.)